Trading status Status de
  • Prices realtime
    • Indizes
      • UC DAX
      • UC MDAX
      • UC TECDAX
      • UC DJI
      • UC ESTOXX
      • UC NASQAD 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 1010
  • 1011
  • 1012
  • …
  • ›
  • »

2026-08-02

Should I buy ANZ Bank shares for passive income?

2026-08-02

Rio Tinto′s copper pivot just paid off in a big way

2026-08-02

Costco′s changes fix members′ biggest problems

2026-08-02

GlobalFoundries Stock Has Slid Below $50. What an Insider Filing Does and Doesn′t Tell You

2026-08-02

What Does Planet Labs CFO Ashley Johnson′s Sale of Shares Worth $2.4 Million Mean for Investors?

2026-08-02

A GlobalFoundries Director Sold Ahead of Earnings. Here′s What Long-Term Investors Should Know

2026-08-02

An IQVIA Insider Sold Just Before the Stock Slipped. Here′s What Long-Term Investors Should Know

2026-08-02

AstraZeneca, Bristol Myers Squibb Reportedly in Talks for $400 Billion Merger - Benzinga

2026-08-02

Consumer goods giant quietly wows investors after terrible streak

2026-08-02

An IQVIA Insider Just Sold Over $1 Million in Stock. Here′s What Long-Term Investors Should Know

2026-08-02

AstraZeneca in talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

2026-08-02

AstraZeneca holds talks with Bristol Myers Squibb on $400 billion megadeal, FT reports

  • «
  • ‹
  • …
  • 1010
  • 1011
  • 1012
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies